糖尿病患者泌尿系感染病原菌的耐药现状  

Current status of antimicrobial resistance of pathogenic bacteria causing urinary tract infections in diabetics

作　　者：黄伟[1] 李颖[1] 周锋[1] 罗艳[1] 胡桂英[1] 孔繁聪[1] 

机构地区：[1]武汉科技大学附属普仁医院内分泌科,湖北武汉430081

出　　处：《中华医院感染学杂志》2012年第4期852-853,共2页Chinese Journal of Nosocomiology

摘　　要：目的探讨医院糖尿病(DM)患者泌尿系感染病原菌的耐药现状,为合理使用抗菌药物提供科学依据。方法回顾性调查医院267例糖尿病合并泌尿系感染患者的病案资料。结果感染病原菌中大肠埃希菌居首位,占61.0%,肠球菌属第2位,占11.2%;除革兰阴性杆菌对亚胺培南、美罗培南100.0%敏感,革兰阳性球菌对万古霉素、替考拉宁100.0%敏感以外,所有病原菌对常用抗菌药物产生了不同程度的耐药性。结论糖尿病患者泌尿系感染病原菌耐药性十分严重,医院应加强力度,遏制细菌耐药性快速增长的不良趋势。OBJECTIVE To approach antimicrobial resistance of pathogenic bacteria causing urinary tract infections in diabetics and offer scientific evidence for reasonable use of antibiotics.METHODS The retrospective review was performed for 267 cases of urinary tract infections in diabetics.RESULTS Among pathogenic bacteria,Escherichia coli（61.0%） ranked the top one.Enterococcus ranked the second and accounted for 11.2%.All strains were resistant to the other commonly used antibiotics to varying degrees except for 100.0% susceptibility to imipenem and meropenem against gram-negative bacilli,and to vancomycin and teicoplanin against gram-positive cocci.CONCLUSION Drug resistance of pathogenic bacteria causing urinary tract infections is very serious in diabetics.Hospital should strengthen administration to restrain the rapidly increasing tendency of antimicrobial resistance.

关 键 词：糖尿病 泌尿系感染 病原菌 耐药性 

分 类 号：R378[医药卫生—病原生物学]